Advertisement

Advertisement

SANA Stock Latest News

Sana Biotechnology Shareholders Reelect Directors and Ratify Auditor

Company AnnouncementsSana Biotechnology Shareholders Reelect Directors and Ratify Auditor

Sana Biotechnology Raises $69 Million Through Equity Offering

PremiumCompany Announcements

Sana Biotechnology Raises $69 Million Through Equity Offering

28d ago

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

PremiumThe Fly

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

1M ago

Sana Biotechnologies: Mayo Collaboration and HIP Platform Progress Reinforce Buy Rating and Unchanged $7 Price Target

PremiumRatings

Sana Biotechnologies: Mayo Collaboration and HIP Platform Progress Reinforce Buy Rating and Unchanged $7 Price Target

1M ago

Frahm Initiates Buy on Sana Biotechnology, Citing Differentiated In Vivo CAR‑T Pipeline and Strong Cash Runway into 2027

PremiumRatings

Frahm Initiates Buy on Sana Biotechnology, Citing Differentiated In Vivo CAR‑T Pipeline and Strong Cash Runway into 2027

1M ago

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

PremiumThe FlySana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

1M ago

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

The Fly

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

1M ago

SANA Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

SANA Earnings Report this Week: Is It a Buy, Ahead of Earnings?

1M ago

Sana Biotechnology options imply 5.3% move in share price post-earnings

PremiumThe Fly

Sana Biotechnology options imply 5.3% move in share price post-earnings

1M ago

Sana Biotechnology Rebalances Board Classes With Director Shift

PremiumCompany Announcements

Sana Biotechnology Rebalances Board Classes With Director Shift

2M ago

Sana Biotechnology price target raised to $7 from $6 at Wedbush

PremiumThe Fly

Sana Biotechnology price target raised to $7 from $6 at Wedbush

2M ago

Sana Biotechnology: Mayo Clinic Collaboration and UP421 Data De‑Risk SC451 and Support Buy Rating on Type 1 Diabetes Momentum

PremiumRatings

Sana Biotechnology: Mayo Clinic Collaboration and UP421 Data De‑Risk SC451 and Support Buy Rating on Type 1 Diabetes Momentum

2M ago

Sana Biotechnology Secures Strategic Equity Investment from Mayo

PremiumCompany AnnouncementsSana Biotechnology Secures Strategic Equity Investment from Mayo

2M ago

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

The Fly

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

2M ago

Durable HIP Technology Data De‑Risks Sana Biotechnology’s SC451 Program and Supports Buy Rating

Ratings

Durable HIP Technology Data De‑Risks Sana Biotechnology’s SC451 Program and Supports Buy Rating

3M ago

Sana announces follow-up results from first-in-human study transplanting UP421

PremiumThe Fly

Sana announces follow-up results from first-in-human study transplanting UP421

3M ago

Sana Biotechnology: Advancing T1D and In Vivo CAR-T Programs with 2026 Catalysts and Solid Cash Runway Supporting Buy Rating

PremiumRatings

Sana Biotechnology: Advancing T1D and In Vivo CAR-T Programs with 2026 Catalysts and Solid Cash Runway Supporting Buy Rating

3M ago

AI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks

PremiumCompany Announcements

AI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks

3M ago

Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating

PremiumRatings

Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating

3M ago

Sana Biotechnology files automatic mixed securities shelf

PremiumThe FlySana Biotechnology files automatic mixed securities shelf

3M ago

Sana Biotechnology Updates ATM Program to Support Development

Company Announcements

Sana Biotechnology Updates ATM Program to Support Development

3M ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

The Fly

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >